118 related articles for article (PubMed ID: 25337626)
21. Flu Vaccine-Too Much of a Good Thing?
Treanor J
J Infect Dis; 2017 Apr; 215(7):1017-1019. PubMed ID: 28180278
[No Abstract] [Full Text] [Related]
22. Influenza Cataclysm, 1918.
Morens DM; Taubenberger JK
N Engl J Med; 2018 Dec; 379(24):2285-2287. PubMed ID: 30575465
[No Abstract] [Full Text] [Related]
23. Gene found to protect people from avian influenza.
Vet Rec; 2023 Jul; 193(1):8. PubMed ID: 37417488
[No Abstract] [Full Text] [Related]
24. Asynchrony between virus diversity and antibody selection limits influenza virus evolution.
Morris DH; Petrova VN; Rossine FW; Parker E; Grenfell BT; Neher RA; Levin SA; Russell CA
Elife; 2020 Nov; 9():. PubMed ID: 33174838
[TBL] [Abstract][Full Text] [Related]
25. Passive immunotherapies for the next influenza pandemic.
Focosi D; Franchini M; Senefeld JW; Joyner MJ; Sullivan DJ; Pekosz A; Maggi F; Casadevall A
Rev Med Virol; 2024 May; 34(3):e2533. PubMed ID: 38635404
[TBL] [Abstract][Full Text] [Related]
26. Gene-edited chickens partially resistant to AI.
Gray A
Vet Rec; 2023 Oct; 193(8):305. PubMed ID: 37861158
[No Abstract] [Full Text] [Related]
27. H5N1 Avian Influenza Pre-pandemic Vaccine Strains in China.
Bo H; Dong LB; Zhang Y; Dong J; Zou SM; Gao RB; Wang da Y; Shu YL
Biomed Environ Sci; 2014 Oct; 27(10):763-9. PubMed ID: 25341811
[TBL] [Abstract][Full Text] [Related]
28. Antibody landscapes after influenza virus infection or vaccination.
Fonville JM; Wilks SH; James SL; Fox A; Ventresca M; Aban M; Xue L; Jones TC; Le NMH; Pham QT; Tran ND; Wong Y; Mosterin A; Katzelnick LC; Labonte D; Le TT; van der Net G; Skepner E; Russell CA; Kaplan TD; Rimmelzwaan GF; Masurel N; de Jong JC; Palache A; Beyer WEP; Le QM; Nguyen TH; Wertheim HFL; Hurt AC; Osterhaus ADME; Barr IG; Fouchier RAM; Horby PW; Smith DJ
Science; 2014 Nov; 346(6212):996-1000. PubMed ID: 25414313
[TBL] [Abstract][Full Text] [Related]
29. H7N9: preparing for the unexpected in influenza.
Jernigan DB; Cox NJ
Annu Rev Med; 2015; 66():361-71. PubMed ID: 25386931
[TBL] [Abstract][Full Text] [Related]
30. Avian influenza A(H5N1) and A(H9N2) seroprevalence and risk factors for infection among Egyptians: a prospective, controlled seroepidemiological study.
Gomaa MR; Kayed AS; Elabd MA; Zeid DA; Zaki SA; El Rifay AS; Sherif LS; McKenzie PP; Webster RG; Webby RJ; Ali MA; Kayali G
J Infect Dis; 2015 May; 211(9):1399-407. PubMed ID: 25355942
[TBL] [Abstract][Full Text] [Related]
31. Phase I/II randomized double-blind study of the safety and immunogenicity of a nonadjuvanted vero cell culture-derived whole-virus H9N2 influenza vaccine in healthy adults.
Aichinger G; Grohmann-Izay B; van der Velden MV; Fritsch S; Koska M; Portsmouth D; Hart MK; El-Amin W; Kistner O; Barrett PN
Clin Vaccine Immunol; 2015 Jan; 22(1):46-55. PubMed ID: 25355797
[TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus vaccines: WHO position paper, October 2014.
Wkly Epidemiol Rec; 2014 Oct; 89(43):465-91. PubMed ID: 25346960
[No Abstract] [Full Text] [Related]
33. Influenza A virus uses the aggresome processing machinery for host cell entry.
Banerjee I; Miyake Y; Nobs SP; Schneider C; Horvath P; Kopf M; Matthias P; Helenius A; Yamauchi Y
Science; 2014 Oct; 346(6208):473-7. PubMed ID: 25342804
[TBL] [Abstract][Full Text] [Related]
34. A Single Dose of an Avian H3N8 Influenza Virus Vaccine Is Highly Immunogenic and Efficacious against a Recently Emerged Seal Influenza Virus in Mice and Ferrets.
Baz M; Paskel M; Matsuoka Y; Zengel JR; Cheng X; Treanor JJ; Jin H; Subbarao K
J Virol; 2015 Jul; 89(13):6907-17. PubMed ID: 25903333
[TBL] [Abstract][Full Text] [Related]
35. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2015 Mar; 90(12):109-20. PubMed ID: 25796641
[No Abstract] [Full Text] [Related]
36. Dissemination, divergence and establishment of H7N9 influenza viruses in China.
Lam TT; Zhou B; Wang J; Chai Y; Shen Y; Chen X; Ma C; Hong W; Chen Y; Zhang Y; Duan L; Chen P; Jiang J; Zhang Y; Li L; Poon LL; Webby RJ; Smith DK; Leung GM; Peiris JS; Holmes EC; Guan Y; Zhu H
Nature; 2015 Jun; 522(7554):102-5. PubMed ID: 25762140
[TBL] [Abstract][Full Text] [Related]
37. Characterization of influenza A (H7N9) viruses isolated from human cases imported into Taiwan.
Yang JR; Kuo CY; Huang HY; Wu FT; Huang YL; Cheng CY; Su YT; Wu HS; Liu MT
PLoS One; 2015; 10(3):e0119792. PubMed ID: 25748033
[TBL] [Abstract][Full Text] [Related]
38. Diverse heterologous primary infections radically alter immunodominance hierarchies and clinical outcomes following H7N9 influenza challenge in mice.
Duan S; Meliopoulos VA; McClaren JL; Guo XZ; Sanders CJ; Smallwood HS; Webby RJ; Schultz-Cherry SL; Doherty PC; Thomas PG
PLoS Pathog; 2015 Feb; 11(2):e1004642. PubMed ID: 25668410
[TBL] [Abstract][Full Text] [Related]
39. Antibodies to antigenic site A of influenza H7 hemagglutinin provide protection against H7N9 challenge.
Schmeisser F; Vasudevan A; Verma S; Wang W; Alvarado E; Weiss C; Atukorale V; Meseda C; Weir JP
PLoS One; 2015; 10(1):e0117108. PubMed ID: 25629172
[TBL] [Abstract][Full Text] [Related]
40. Raising expectations for subunit vaccine.
Schiller JT; Lowy DR
J Infect Dis; 2015 May; 211(9):1373-5. PubMed ID: 25420478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
